Bio-FD&C Co

Bio-FD&C Co Capital Expenditures

The Capital Expenditures (CapEx) of Bio-FD&C Co (251120.KQ) as of Oct 21, 2026 is -1.05 B KRW. In the previous year, Capital Expenditures (CapEx) was -1.30 B KRW — a change of -19.14% (higher).

Capital Expenditures

-1.05 BKRW

YoY

-19.14%

Last updated:

Capital Expenditures (CapEx) of Bio-FD&C Co is 2025 -1.05 B KRW. Capital Expenditures (CapEx) of Bio-FD&C Co was 2024 -1.30 B KRW. It decreases by -19.14% higher compared to the previous year.

The Bio-FD&C Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-1.13 B KRW
Jan 1, 2019
-282.68 M KRW
Jan 1, 2020
-1.89 B KRW
Jan 1, 2021
-7.02 B KRW
Jan 1, 2022
-152.44 M KRW
Jan 1, 2023
-2.33 B KRW
Jan 1, 2024
-1.30 B KRW
Jan 1, 2025
-1.05 B KRW
The Bio-FD&C Co Capital Expenditures history
YEARCapital ExpendituresYoY
-1.05 BKRW-19.14%
-1.30 BKRW-44.33%
-2.33 BKRW+1,427.99%
-152.44 MKRW-97.83%
-7.02 BKRW+271.54%
-1.89 BKRW+568.13%
-282.68 MKRW-75.03%
-1.13 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Bio-FD&C Co Stock analysis

What does Bio-FD&C Co do? Bio-FD&C Co., Ltd. develops bio and health technologies, focusing on manufacturing and selling soybean callus culture extract, clock stem cell, centella asiatica, callus extract, aloe barbadensis phytoplaceta extract, prunus mume phytoplacenta extract, secale cereale adventitious root extract, and acanthopanax koreanum adventitious root culture extract. These products serve as key materials for cosmeceuticals, health functional foods, and pharmaceuticals, targeting companies in the cosmetics, health supplement, and pharmaceutical industries. The company generates revenue through direct sales of these specialized extracts to manufacturers who incorporate them into their final products. The firm's product portfolio includes unique bioactive compounds like centella asiatica and prunus mume phytoplacenta extract, which are used in high-value applications within the cosmeceutical and pharmaceutical sectors. By supplying these specialized ingredients, Bio-FD&C Co., Ltd. caters to clients seeking natural, plant-based solutions for product development. Its focus on extract-based materials positions it as a supplier for companies developing innovative health and beauty products. Bio-FD&C Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Bio-FD&C Co stock

Capital Expenditures (CapEx) of Bio-FD&C Co is -1.05 B KRW in 2025.

Capital Expenditures (CapEx) of Bio-FD&C Co changed from -1.30 B KRW to -1.05 B KRW, representing a -19.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Bio-FD&C Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Bio-FD&C Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Cash Flow — Bio-FD&C Co

Operating Cash FlowCapital ExpendituresFree Cash FlowFCF per ShareDividends PaidShare BuybacksInvesting Cash FlowFinancing Cash FlowCapEx / RevenueCash Flow per ShareStock-Based CompensationChange in Working CapitalAcquisitions (Net)Net Change in CashCapEx/OCFFCF/Net IncomeFCF ConversionCash ConversionTotal Shareholder PayoutCapEx/D&A

All Key Metrics — Bio-FD&C Co